Merck veteran Fiona H. Marshall has been tapped as president of the Novartis Institutes for BioMedical Research (NIBR). She takes over from Jay Bradner, who will leave the company effective Oct. 31. 

Moderna

Canada on Thursday authorized Moderna Inc.’s bivalent COVID-19 vaccine booster for people aged 18 and older, according to a notice posted on the government’s website.

Germany COVID-19 vaccination

Germany can next week start using COVID-19 vaccines which have been adapted for the Omicron variant and got approval for use in the European Union on Thursday, Health Minister Karl Lauterbach said.

The Serum Institute of India (SII), the world’s biggest vaccine maker, has developed the country’s first cervical cancer shot that will hit the market soon, the company and the government said on Thursday.

FDA

Xenpozyme is the first approved medication to treat symptoms that are not related to the central nervous system in patients with ASMD, a rare genetic disease that causes premature death.

FDA

Today, the agency amended the EUAs of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination.

COVID death toll

Life expectancy fell in the United States in 2021 to its lowest since 1996, the second year of a historic retreat due to COVID-19 deaths, provisional government data showed on Wednesday.

Amgen announced Tuesday morning that its initial Phase III data of its oral drug Lumakras (sotorasib) met its primary endpoint of progression-free survival in patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC).

opioids

The long-awaited review of problematic prescribing of opioids is taking longer than observers had hoped. Studies of this extended use of the pain medications have lagged for years beyond their expected completion, said FDA Commissioner Robert Califf to the Associated Press.

COVID-19 masking

Omicron-adapted vaccines will be delivered to the European Union within days of regulatory approval, European member of parliament Peter Liese said on Wednesday.